[Three Cases of Appendiceal Goblet Cell Adenocarcinoma in Our Institution]

Gan To Kagaku Ryoho. 2023 Jun;50(6):727-729.
[Article in Japanese]


Appendiceal goblet cell adenocarcinoma(AGCA)is a newly designated pathological term adopted in the 5th edition of the WHO classification. It is synonymous with goblet cell carcinoid, which was previously categorized as a part of appendiceal carcinoid. However, since 2018, it has been classified as a subtype of adenocarcinoma. We have experienced 3 cases of this relatively rare tumor, of which 2 were initially diagnosed with acute appendicitis and were diagnosed with AGCA by pathological examination after an emergency appendectomy. Each of them underwent additional ileocolic resection with lymph node dissection as the second surgery. In the 3rd case, an appendiceal tumor was detected during preoperative examinations for an ovarian tumor. Staging laparoscopy revealed comorbid peritoneal dissemination, and only the appendix and right ovary were removed in the consecutive surgery. The ovarian tumor was pathologically diagnosed as a metastasis of AGCA. In this case, the introduction of oxaliplatin-based systemic chemotherapy after surgery achieved a complete response after more than 2 years. Although no recurrence has been observed in all 3 cases to date, AGCA is considered highly malignant compared to conventional appendiceal carcinoids. Therefore, it is crucial to practice multidisciplinary treatments, including sufficient radical surgery based on a precise diagnosis of AGCA, as is performed for advanced colorectal cancer.

Publication types

  • English Abstract

MeSH terms

  • Adenocarcinoma* / surgery
  • Appendiceal Neoplasms* / surgery
  • Carcinoid Tumor* / surgery
  • Female
  • Goblet Cells
  • Humans
  • Ovarian Neoplasms*

Supplementary concepts

  • Carcinoid Tumors, Intestinal